Search

everythinglearnresearchcommunity

for

Search:↓

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

PDGF signaling is crucial for cell development, wound healing, and fluid regulation in the body.

Applying a specific inhibitor lightens skin and hair color.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Gefitinib can cause hair loss without scarring.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

New compounds were found to help increase hair growth and decrease hair loss.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

PDGF isoforms can promote and sustain hair growth.

The document does not give specific results for hair loss treatment effectiveness.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Enzymes that change arginine to citrulline are important for skin barrier and hair formation, and their malfunction can lead to skin conditions and hair disorders.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.